Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jim Pickett

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Plos One|November 13, 2012
Is wetter better? An evaluation of over-the-counter personal lubricants for safety and anti-HIV-1 activityCharlene S Dezzutti, Elizabeth R Brown, Bernard Moncla, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 9, 2024
Filling in the Gaps: Updates on Doxycycline Prophylaxis for Bacterial Sexually Transmitted InfectionsAniruddha Hazra, Moira C McNulty, Maria Pyra, et al.
Microbiology Spectrum|March 23, 2026
Mucosal tenofovir 1% gel stimulates cell proliferation and type I/III interferon pathwaysSean M Hughes, Fernanda L Calienes, Claire N Levy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 18, 2016
MTN-017: A Rectal Phase 2 Extended Safety and Acceptability Study of Tenofovir Reduced-Glycerin 1% GelRoss D Cranston, Javier R Lama, Barbra A Richardson, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Plos One|November 13, 2012
Is wetter better? An evaluation of over-the-counter personal lubricants for safety and anti-HIV-1 activityCharlene S Dezzutti, Elizabeth R Brown, Bernard Moncla, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 9, 2024
Filling in the Gaps: Updates on Doxycycline Prophylaxis for Bacterial Sexually Transmitted InfectionsAniruddha Hazra, Moira C McNulty, Maria Pyra, et al.
Microbiology Spectrum|March 23, 2026
Mucosal tenofovir 1% gel stimulates cell proliferation and type I/III interferon pathwaysSean M Hughes, Fernanda L Calienes, Claire N Levy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 18, 2016
MTN-017: A Rectal Phase 2 Extended Safety and Acceptability Study of Tenofovir Reduced-Glycerin 1% GelRoss D Cranston, Javier R Lama, Barbra A Richardson, et al.
Pageof 3